{ }
Recipharm is expanding its Monts production center in France to manufacture the Moderna vaccine, creating 100 jobs, despite challenges in recruiting skilled talent. The decision to relocate production is driven by economic interests, environmental concerns, and a desire to strengthen national sovereignty in the face of global supply chain vulnerabilities highlighted by the Covid-19 pandemic. The SYMBIOSE project represents a significant investment in the future of French industry, aiming to balance relocation with securing critical supplies from various regions.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.